Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress Life Science Investing
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update Life Science Investing
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow Life Science Investing
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones Life Science Investing
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City Life Science Investing
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors Pharmaceutical Investing
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
